Vistagen Therapeutics Inc

Penny Stocks Biotech Stocks Healthcare Stocks

$0.23

-0.53 (-70.26%)

As of Jun 30, 10:47 PM ET ·

Analyst Consensus

Sell

Analysts

Moderate

Coverage

Buy 0 0%

Hold 7 70%

Sell 3 30%

Price Target

Analyst Price Target +21,789.4% upside

Low Target $36.23

Average Target $49.47

High Target $53.77

Current Price $0.23

Current
$0.23

Target
$49.47

$36.23 $49.47 avg $53.77

Scenario Analysis

Bear Case

$36.23

15,931.0%

Low target

Base Case

$49.47

+21,789.4%

Avg target

Bull Case

$53.77

+23,692.0%

High target

Risk/Reward

1.5x

Balanced

Price in Context

52-Week High

$5.14

-95.6% from high

52-Week Low

$0.43

+-47.4% from low

Target vs 52W High

$49.47

+862.5% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	40	78%	$257.58	+2.4%
AMGN Amgen Inc	Hold	44	50%	$190.87	-47.3%
GILD Gilead Sciences Inc	Strong Buy	39	82%	$362.68	+187.1%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	40	83%	$438.34	-11.8%
REGN Regeneron Pharmaceuticals	Buy	38	71%	$76.80	-87.7%
ALNY Alnylam Pharmaceuticals Inc	Strong Buy	37	76%	$102.31	-66.0%
RVMD Revolution Medicines Inc	Strong Buy	27	96%	$114.11	-39.1%
NTRA Natera Inc	Strong Buy	27	89%	$142.91	-47.4%